171 related articles for article (PubMed ID: 19131794)
21. Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
Chang YC; Dai YC; Chow NH
Hepatogastroenterology; 2003; 50(53):1637-40. PubMed ID: 14571804
[TBL] [Abstract][Full Text] [Related]
22. [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma].
Zhang ZH; Ma LW; Song SB; Xiu DR; Wang JJ; Yang XX; Jia YM
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):45-7. PubMed ID: 15771799
[TBL] [Abstract][Full Text] [Related]
23. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
[TBL] [Abstract][Full Text] [Related]
25. The effect of chemotherapy on hepatoblastoma.
Forouhar FA; Quinn JJ; Cooke R; Foster JH
Arch Pathol Lab Med; 1984 Apr; 108(4):311-4. PubMed ID: 6322723
[TBL] [Abstract][Full Text] [Related]
26. Effect of a new adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion.
Imura S; Ikemoto T; Morine Y; Fujii M; Miyake H; Tashiro S; Shimada M
Hepatogastroenterology; 2008; 55(82-83):615-20. PubMed ID: 18613419
[TBL] [Abstract][Full Text] [Related]
27. Resection of hepatocellular carcinoma with tumor thrombus of the portal vein after neoadjuvant regional chemotherapy.
Kamiyama H; Toyama N; Mori Y; Miyazaki K; Nagano M; Yamada S; Suminaga Y; Konishi F
J Hepatobiliary Pancreat Surg; 2002; 9(6):759-63. PubMed ID: 12658413
[TBL] [Abstract][Full Text] [Related]
28. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
[TBL] [Abstract][Full Text] [Related]
29. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
30. Hepatoid carcinoma of the ovary and management.
Lazaro J; Rubio D; Repolles M; Capote L
Acta Obstet Gynecol Scand; 2007; 86(4):498-9. PubMed ID: 17486476
[TBL] [Abstract][Full Text] [Related]
31. Outcome of patients with fibrolamellar hepatocellular carcinoma.
Stipa F; Yoon SS; Liau KH; Fong Y; Jarnagin WR; D'Angelica M; Abou-Alfa G; Blumgart LH; DeMatteo RP
Cancer; 2006 Mar; 106(6):1331-8. PubMed ID: 16475212
[TBL] [Abstract][Full Text] [Related]
32. [A particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant].
Zermani R; Charfi L; Kourda N; Farah F; Rammeh S; Trabelsi O; Zaouch A; Ben Jilani S
Tunis Med; 2005 Jul; 83(7):419-21. PubMed ID: 16220700
[TBL] [Abstract][Full Text] [Related]
33. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
34. Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma.
Nagasue N; Yukaya H; Chang YC; Yamanoi A; Kohno H; Hayashi T; Nakamura T
Surg Gynecol Obstet; 1990 Sep; 171(3):217-22. PubMed ID: 1696750
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Liu-Mares W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
J Clin Oncol; 2002 Jun; 20(12):2789-97. PubMed ID: 12065555
[TBL] [Abstract][Full Text] [Related]
36. [Chemotherapy for hepatocellular carcinoma].
Okusaka T; Ueno H; Ikeda M
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
[TBL] [Abstract][Full Text] [Related]
38. Adriamycin and cisplatin for hepatoblastoma.
Quinn JJ; Altman AJ; Robinson HT; Cooke RW; Hight DW; Foster JH
Cancer; 1985 Oct; 56(8):1926-9. PubMed ID: 2411381
[TBL] [Abstract][Full Text] [Related]
39. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
von Schweinitz D; Bürger D; Bode U; Weinel P; Erttmann R; Hecker H; Mildenberger H
Klin Padiatr; 1994; 206(4):282-8. PubMed ID: 7526028
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
